📇 Rhumatologue · SEDAN · (08) · Hospitalier
Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Praticien-chercheur
6 articles scientifiques publiés — formation continue solide
Délais de RDV courts dans la région
79.5 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
83
83 articles ont été cités au moins 83fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
39 450
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
467
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
176
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Thiamine hydrochloride, riboflavin, pyridoxine hydrochloride and biotin hard gelatin capsules prepared in advance and stored for the treatment of pediatric metabolic disease: a safer alternative
2025ArticlePLoS ONE
Low-dose erythromycin in pediatrics: Formulation and stability of 20 mg hard gelatin capsules
2023ArticlePLoS ONE
Pre-formulation and Stability Study of 20-mcg Clonidine Hydrochloride Pediatric Capsules
2022ArticleThe Journal of Pediatric Pharmacology and Therapeutics
Beyond-Use Dates Assignment for Pharmaceutical Preparations: Example of Low-Dose Amiodarone Capsules.
2021ArticleThe Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians
Fragmentation promotes the role of dispersal in determining 10 intermittent headwater stream metacommunities
2020ArticleFreshwater Biology
Bedrock radioactivity influences the rate and spectrum of mutation
2020ArticleeLife
GOTIT: A laboratory application software for optimizing multi‐criteria species‐based research
2020ArticleMethods in Ecology and Evolution
Trophic selectivity in aquatic isopods increases with the availability of resources
2020ArticleFunctional Ecology
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
CABINET DU DR CHRISTOPHE JEAN
12 RUE JEAN JAURES, 08200 SEDAN
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Bone · 2010
Case reports in rheumatology · 2014
Polymyositis is a rare debilitating condition characterized by chronic inflammation and muscle weakness. Standard treatments include corticosteroids and immunosuppressants; however, resistance to these regimens may develop. Intravenous immunoglobulins (IVIg) are thus recommended for patients with drug-resistant polymyositis. The patient presented a resistant polymyositis with severe muscle weakness, increasing dysphagia, and significant loss in weight. Subcutaneous immunoglobulins (SCIg) were initiated after failure of steroids and immunosuppressive drugs. SCIg was given twice per week (2 then 1.3 g/kg/month). Clinical recovery was observed within 2 months after the SCIg initiation. After several injections, the patient showed a progressive improvement in muscle strength. Serum creatine kinase activity decreased to normal levels, and dysphagia was resolved. The SC injections were generally well tolerated and good patient satisfaction was reported. This promising observation suggests that SCIg may be useful in active and refractory polymyositis.
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2022
OBJECTIVE Clonidine hydrochloride is an antihypertensive, centrally acting α2 adrenergic agonist with various pediatric indications. For pediatric patients, 20-mcg clonidine hydrochloride capsules can be compounded from commercial tablets or from a pre-compounded titrated powder. These methods should be compared to ensure the best quality for the high-risk patients, and a beyond-use date should be established. METHODS Eight experimental batches were made from commercial tablets and 8 were made from microcrystalline cellulose (MCC)–based titrated powders. Quality controls were performed to determine the best compounding protocol. Stability study was conducted on capsules compounded with the best method. RESULTS Of 8 batches manufactured from commercial tablets, 7 were compliant for both clonidine mean content and content uniformity, whereas 7 of 8 batches manufactured from titrated powders were not. A clonidine loss during compounding was evidenced by surface sampling analyses. Clonidine hydrochloride 20-mcg capsules' mean content remained higher than 90% of initial content for 1 year when stored at 25°C with 60% relative humidity and protected from light. CONCLUSIONS Commercial tablets should be preferred to 1% clonidine hydrochloride and MCC titrated powder made from the active pharmaceutical ingredient. Twenty-microgram clonidine hydrochloride capsules made from commercial tablets are stable for 1 year when stored under managed ambient storage condition.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
International journal of pharmaceutical compounding · 2026 · Journal Article
Dho L, Taleb SA, Kireche L, Rathelot P, et al.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2025 · Journal Article
Dubois L, Bouguergour C, Paoli-Lombardo R, Castera-Ducros C, et al.
PloS one · 2025 · Journal Article
Bonino M, Bouchez A, Kadri A, Jacquet I, et al.
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2022 · Journal Article
Wasilewski M, Curti C, Panuccio C, Bouguergour C, et al.
Case reports in rheumatology · 2014 · Journal Article
Patrick C, Jean-Christophe D, Jean-Charles C, Odile C
Bone · 2010 · Journal Article
Olfa G, Christophe C, Philippe L, Romain S, et al.
CCDC 890164: Experimental Crystal Structure Determination
Related Article: Catherine Gomez, Maxime Gicquel, Jean-Christophe Carry, Laurent Schio, Pascal Retailleau, Arnaud Voituriez, and Angela Marinetti|2013|J.Org.Chem.|78|1488|doi:10.1021/jo302460d
CCDC 898576: Experimental Crystal Structure Determination
Related Article: Polly L. Arnold , Emmalina Hollis , Gary S. Nichol , Jason B. Love , Jean-Christophe Griveau , Roberto Caciuffo , Nicola Magnani , Laurent Maron , Ludovic Castro , Ahmed Yahia , Samuel O. Odoh and Georg
Modelling Ultrafast Exciton Transfer in Fluorene-Based Organic Semiconductors
CCDC 965990: Experimental Crystal Structure Determination
Related Article: Neetu Gupta, Valerie Pons, Romain Noel, David-Alexandre Buisson, Aurelien Michau, Ludger Johannes, Daniel Gillet, Julien Barbier, Jean-Christophe Cintrat|2014|ACS.Med.Chem.Lett.|5|94|doi:10.1021/ml400457
CCDC 938918: Experimental Crystal Structure Determination
Related Article: Pierre Queval, Claire Jahier, Mathieu Rouen, Isabelle Artur, Jean-Christophe Legeay, Laura Falivene, loic Toupet, Christophe Crévisy, Luigi Cavallo, Olivier Basle, Marc Mauduit|2013|Angew.Chem.,Int.Ed.|5
CCDC 961639: Experimental Crystal Structure Determination
Related Article: Pierre Queval, Claire Jahier, Mathieu Rouen, Isabelle Artur, Jean-Christophe Legeay, Laura Falivene, loic Toupet, Christophe Crévisy, Luigi Cavallo, Olivier Basle, Marc Mauduit|2013|Angew.Chem.,Int.Ed.|5
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).